Clover Health Investments
CLOV
157 hedge funds and large institutions have $104M invested in Clover Health Investments in 2023 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 30 closing their positions.
90% more call options, than puts
Call options by funds: $2.42M | Put options by funds: $1.27M
4% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 45
1.58% less ownership
Funds ownership: 32.86% → 31.27% (-1.6%)
10% less funds holding
Funds holding: 175 → 157 (-18)
11% less capital invested
Capital invested by funds: $117M → $104M (-$13.3M)
47% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 30
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$2.68M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
+$2.45M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.1M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$837K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$646K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$2.46M |
| 2 |
Jane Street
New York
|
-$2.46M |
| 3 |
Millennium Management
New York
|
-$1.02M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$747K |
| 5 |
BlackRock
New York
|
-$571K |
CLOV Hedge Fund Activity: Q1 2023 in Review
157 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q1 2023, worth a combined $104M — down 11% from $117M a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of CLOV and 16 opened new positions — a net loss of 14 holders — while 45 trimmed existing stakes and 47 added.
The largest buyer was Renaissance Technologies, adding an estimated $2.68M. The largest seller was Baillie Gifford & Co, exiting entirely with an estimated $2.46M sold.
- 157 institutional investors held Clover Health Investments (CLOV) as of Q1 2023, down from 175 in Q4 2022.
- Funds reported $104M of Clover Health Investments stock for Q1 2023, down 11% quarter-over-quarter.
- 16 funds opened new Clover Health Investments positions in Q1 2023 and 30 closed out, a net change of -14 holders.
- The largest Clover Health Investments buyer in Q1 2023 was Renaissance Technologies, an estimated $2.68M added.
- The largest Clover Health Investments seller in Q1 2023 was Baillie Gifford & Co, an estimated $2.46M sold.
Based on aggregated 13F filings for Q1 2023.